Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus
- 12 August 2008
- journal article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 17 (9) , 1365-1377
- https://doi.org/10.1517/13543784.17.9.1365
Abstract
(2008). Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus. Expert Opinion on Investigational Drugs: Vol. 17, No. 9, pp. 1365-1377. doi: 10.1517/13543784.17.9.1365Keywords
This publication has 74 references indexed in Scilit:
- Pathogenesis and clinical and economic consequences of postoperative ileusAmerican Journal of Health-System Pharmacy, 2007
- Patterns of Gastrointestinal Recovery after Bowel Resection and Total Abdominal Hysterectomy: Pooled Results from the Placebo Arms of Alvimopan Phase III North American Clinical TrialsJournal of the American College of Surgeons, 2007
- Prokinetic Effects of a New Ghrelin Receptor Agonist TZP-101 in a Rat Model of Postoperative IleusDigestive Diseases and Sciences, 2007
- Alvimopan, for Postoperative Ileus Following Bowel ResectionAnnals of Surgery, 2007
- Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgerySurgical Endoscopy, 2005
- Outcomes and prediction of hospital readmission after intestinal surgeryJournal of the American College of Surgeons, 2004
- Preoperative albumin and surgical site identify surgical risk for major postoperative complicationsJournal of Parenteral and Enteral Nutrition, 2003
- Prokinetic effect of erythromycin after colorectal surgeryDiseases of the Colon & Rectum, 2000
- Endogenous morphine levels increase following cardiac surgery as part of the antiinflammatory response?International Journal of Cardiology, 1997
- Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion modelLife Sciences, 1989